Amsterdam, 15 June 2023 – Holland Capital invests in Attenza, a care organization specialized in offering terminal palliative care at home. With the investment Attenza can execute its ambitious growth path.
Palliative terminal care
The aging population in the Netherlands and the increasing number of elderly living at home have led to a higher demand for palliative terminal care at home. Attenza provides this care to patients who wish to spend their last days at home with an intensive need for care. Attenza is able to quickly scale up or down palliative terminal care requests and is up to 24 hours per day available at the patient with a small team of care takers to provide comfort and quality care during the final stage of life. The company uses a proprietary software application, which contributes to the success and self-organization of the team, the quality of care and rapid deployment.
The partnership
Due to the partnership with Holland Capital Attenza can further expand its care services, resulting in nationwide coverage.
Carin van der Kaaden (Director of Attenza): “We are delighted to continue our passion together with Holland Capital. Enabling the highest possible quality of both living and dying at home with a small team of dedicated and well-trained professionals, for patients who have the last wish to pass away at home.”
Margot Engels (Partner Healthcare of Holland Capital): “We are proud to add Attenza to our portfolio of healthcare companies. We look forward to supporting the organization and its management in their growth ambitions.”
Almende has been involved in Attenza as a shareholder since 2017 and has actively supported the establishment and expansion of its proposition.
Jan Peter Larsen, CEO of Almende: “We are proud of the unique concept we have established with Attenza and the impact it has on people’s lives. The arrival of Holland Capital is the next step in Attenza’s ambition to offer this form of care nationwide.”
About Attenza
Attenza, founded in 2015, provides palliative terminal intensive care for individuals with specialized needs. Attenza’s mission is to ensure that everyone can spend their last weeks of their life comfortably at home. This is made possible through the swift and effective deployment of a small team of expert caregivers per patient.
About Holland Capital
Over the past 40 years, Holland Capital has responsibly and successfully invested in over more than 160 SME-companies. With a clear investment strategy Holland Capital is active in the attractive growth markets of Healthcare, Technology and Food & Agri. Holland Capital’s experienced and committed investment team aims to establish an open, sustainable, and professional relationship with the companies they invest in, with the common goal of achieving growth. Holland Capital is backed by a broad network of successful healthcare entrepreneurs in the relevant growth markets.
About Almende
Almende is a Rotterdam-based venture builder that focuses on self-organization and technological innovation with a significant societal impact. With over 20 years of experience, Almende has created and scaled successful startups and scaleups in the fields of robotics, communication, and healthcare.
Quantib presents revolutionary software for dementia and MS diagnosis support and tracking
Rotterdam, The Netherlands – August 1st 2018. Quantib, market leader in artificial intelligence tools for radiology, released a major upgrade of their dementia and MS diagnosis support software Quantib™ ND. A substantial list of new features supporting the diagnosis...
Quantib presenteert revolutionaire software voor ondersteuning en tracking van dementie en MS-diagnose
Rotterdam, Nederland, 1 augustus 2018 - Quantib, marktleider in hulpmiddelen voor kunstmatige intelligentie voor radiologie, heeft een belangrijke upgrade van hun dementie en MS-diagnose-ondersteuningssoftware Quantib ™ ND uitgebracht. Een substantiële lijst met...
MedAngel takes away doubts about the effectiveness of medication
Digital healthcare startup receives investment from Holland Venture and Oost NLApeldoorn/Amsterdam, 13th of July 2018 – Uncertainties regarding the effectiveness of injectable medications is a major concern for millions of patients. There are many factors that can...
MedAngel neemt twijfels over werkzaamheid medicatie weg
Digitale healthcare start-up ontvangt investering van Holland Venture en Oost NL Apeldoorn/Amsterdam, 13 juli 2018 - Onzekerheid over de werking van je medicijnen, geen controle hebben over hoe je dag loopt, het houdt veel chronisch zieke patiënten bezig. Er zijn...
Avensus Group expands its security activitities by acquiring auditconnect
Amsterdam, 6th of July 2018 – Avensus Group acquires AuditConnect at the beginning of July 2018. The company focusses, with audit- and consultancy-activities, on improving the security- and IT-processes at large and medium-sized companies. The acquisition fits...
Avensus groep zet volgende stap in buy-and-build strategie met overname auditconnect
Amsterdam, 6 juli 2018 – Avensus Groep neemt vanaf begin juli 2018 AuditConnect over. De onderneming richt zich met audit- en consultancy-activiteiten op het verbeteren van de security- en IT-processen bij grote en middelgrote organisaties. Deze overname past...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl